XML 65 R52.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition - Schedule of Revenues from Major Customers (Detail) - Product Concentration Risk [Member] - Revenue Benchmark [Member]
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Largest Customer | HEPLISAV-B        
Concentration Risk [Line Items]        
Percentage of product revenue 22.00% 28.00% 21.00% 25.00%
Second Largest Customer | HEPLISAV-B        
Concentration Risk [Line Items]        
Percentage of product revenue 20.00% 25.00% 21.00% 22.00%
Third Largest Customer | HEPLISAV-B        
Concentration Risk [Line Items]        
Percentage of product revenue 19.00% 17.00% 18.00% 21.00%
Largest Collaboration Partner | CpG 1018        
Concentration Risk [Line Items]        
Percentage of product revenue 62.00% 71.00% 45.00% 71.00%
Second Largest Collaboration Partner | CpG 1018        
Concentration Risk [Line Items]        
Percentage of product revenue 30.00% 25.00% 29.00% 25.00%